Oncology
David Vesole, MD
Co-Chief, Myeloma Division; Director, Myeloma Research, John Theurer Cancer Center; Professor of Medicine, Georgetown University
David H. Vesole, MD, PhD, FACP, is a hematologist-oncologist specializing in plasma cell dyscrasias, with a primary focus on multiple myeloma, monoclonal gammopathy of undetermined significance (MGUS), amyloidosis, and Waldenstrom’s macroglobulinemia. He serves adult patients, including those with refractory or relapsed disease requiring advanced therapies such as stem cell transplantation. As Co-Chief of the Myeloma Division and Director of Myeloma Research at the John Theurer Cancer Center at
40+
Years in Practice
Credentials
Board Certifications
- Hematology
- Medical Oncology
- Internal Medicine
Education & Training
- Northwestern University Medical School — M.D.
- Medical University of South Carolina — Ph.D., Immunology and Microbiology
- University of Iowa Hospitals and Clinics — Fellowship, Medical Oncology and Hematology
- University of Iowa Hospitals and Clinics — Residency, Internal Medicine
- University of Iowa — B.S.
Recognition & Leadership
Leadership Roles
- Director, Myeloma Research, John Theurer Cancer Center
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- Hackensack University Medical Center
- MedStar Georgetown University Hospital
Languages
English, Spanish
Experience
40+ years in practice